Biotechnology Stocks II Performance Guide: UroGen Pharma Ltd. (URGN)
URGN has no dividends.
Table and Chart of URGN Performance
See what a $1,000 investment in URGN is worth today.
Values are based on monthly closes adjusted for splits and dividends from Alpha Vantage.
| URGN Returns | |
|---|---|
| Start Date | Jun-30-2017 |
| Start Price | $18.06 |
| End Date | May-16-2024 |
| End Price | $13.21 |
| # Prices | 84 |
| Min Date | May-31-2022 |
| Min Price | $5.32 |
| Max Date | May-31-2018 |
| Max Price | $60.12 |
| Total Return | -26.85% |
| Annualized Return | -4.37% |
| Current Value of $1,000 Purchase | $731 |
| Number Returns | 3,486 |
| Average Return | -29.13% |
| Number Profitable Returns | 663 |
| Percent Profitable Returns | 19.02% |
| Number Unprofitable Returns | 2,823 |
| Percent Unprofitable Returns | 80.98% |
| Profitable to Unprofitable Returns Ratio | 0.23 |
| URGN Data | |
|---|---|
| VALUATION DATA | |
| Market Capitalization | $497,873,000 |
| Beta | 1.093 | Price to Sales | 6.23 |
| Earnings per Share | $-3.2200 |
| PE Ratio | None |
| PE to Growth Ratio | 0 |
| Price to Book | 16.05 |
| PRICE DATA | |
| 52 Week High | $24.13 |
| 52 Week Low | $8.69 |
| Analyst Target Price | $38 |
| 50-Day Moving Average | $14.58 |
| 200-Day Moving Average | $15.27 |
| FINANCIAL DATA | |
| Revenue per Share | $2.688 |
| Revenue | $84,302,000 |
| Profit Margin | -123.7% |
| Return on Equity | -1481% |
| Stock Dividend, Valuation, Price and Financial Data Input | |
URGN Compare Returns with S&P 500
URGN Trendline Chart
URGN Moving Average Chart
URGN Stock Return Map - See Patterns of Gains and Losses
URGN Stock Returns/Purchase Dates